Gilead Sciences Inc/ US3755581036 /
2024-11-14 3:46:01 PM | Chg. -0.5850 | Volume | Bid3:46:01 PM | Ask3:46:01 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
92.0450USD | -0.63% | 480,077 Turnover: 31.8 mill. |
92.0200Bid Size: 100 | 92.0700Ask Size: 400 | 114.97 bill.USD | 3.25% | 20.32 |
Assets
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 1,166.2000 | 1,674 | 2,276 | 2,865 | 3,295 | ||||||
Intangible Assets | 11,900.1000 | 11,073 | 10,247 | 8,971 | 17,100 | ||||||
Long-Term Investments | 439 | 1,598 | 11,601 | 20,485 | 11,184 | ||||||
Fixed Assets | - | 16,950 | 27,076 | 36,532 | 38,460 | ||||||
Inventories | 2,055.8000 | 1,386 | 1,955 | 1,587 | 801 | ||||||
Accounts Receivable | 2,100.3000 | 4,635 | 5,854 | 4,514 | 3,851 | ||||||
Cash and Cash Equivalents | 2,112.8000 | 10,027 | 12,851 | 8,229 | 7,588 | ||||||
Current Assets | 7,273.8000 | 17,714 | 24,763 | 20,445 | 31,823 | ||||||
Total Assets | 22,496.8000 | 34,664 | 51,839 | 56,977 | 70,283 |
Liabilities
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 1,255.9000 | 955 | 1,178 | 1,206 | 814 | ||||||
Long-term debt | - | 11,921 | 21,195 | 26,346 | 30,795 | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | 94.2000 | 156 | - | - | - | ||||||
Liabilities | 10,752.3000 | 18,845 | 32,726 | 37,614 | 49,782 | ||||||
Share Capital | 1.5340 | 2 | 1 | 1 | 1 | ||||||
Total Equity | 11,369.1000 | 15,819 | 19,113 | 19,363 | 20,501 | ||||||
Minority Interests | 375.4000 | 393 | 579 | 476 | 59 | ||||||
Total liabilities equity | 22,496.8000 | 34,664 | 51,839 | 56,977 | 70,283 |
Income Statement
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 11,201.7000 | 24,890 | 32,639 | 30,390 | 26,107 | ||||||
Depreciation (total) | - | 125 | 161 | - | - | ||||||
Operating Result | 4,524 | 15,265 | 22,193 | 17,633 | 14,124 | ||||||
Interest Income | -306.9000 | -412 | -688 | -964 | -1,118 | ||||||
Income Before Taxes | 4,208.2000 | 14,856 | 21,659 | 17,097 | 13,529 | ||||||
Income Taxes | 1,150.9000 | 2,797 | 3,553 | 3,609 | 8,885 | ||||||
Minority Interests Profit | 17.5000 | 42 | -2 | -13 | 16 | ||||||
Net Income | 3,074.8000 | 12,101 | 18,108 | 13,501 | 4,628 |
Per Share
Cash Flow
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 3,105 | 12,818 | 20,329 | 16,669 | 11,898 | ||||||
Cash Flow from Investing Activities | -254.4000 | -1,823 | -12,475 | -11,985 | -16,069 | ||||||
Cash Flow from Financing | -2,543.9000 | -3,025 | -4,963 | -9,347 | 3,393 | ||||||
Decrease / Increase in Cash | 309.1000 | 7,914 | 2,824 | -4,622 | -641 | ||||||
Employees | 6,100 | 7,000 | 8,000 | 9,000 | 10,000 |